EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Sidhanth Chandra, Robert J Vassar iD

Immunological Reviews · 2024-10 · 327 (1) · 33-42

DOI: 10.1111/imr.13412 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 23.10.2024. Verfasst von Sidhanth Chandra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Brain-Gut Axis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, Cure Alzheimer's Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common neurodegenerative disorder and cause of dementia. Despite the prevalence of AD, there is a lack of effective disease modifying therapies. Recent evidence indicates that the gut microbiome (GMB) may play a role in AD through its regulation of innate and adaptive immunity. Gut microbes regulate physiology through their production of metabolites and byproducts. Microbial metabolites may be beneficial or detrimental to the pathogenesis and progression of inflammatory diseases. A better understanding of the role GMB‐derived metabolites play in AD may lead to the development of therapeutic strategies for AD. In this review, we summarize the function of bioactive GMB‐derived metabolites and byproducts and their roles in AD models. We also call for more focus on this area in the gut–brain axis field in order to create effective therapies for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeBrain-Gut AxisHumansAnimalsImmunity, InnateAdaptive Immunity

Stichwörter der Autor:innen

Alzheimer's diseasegut microbiomeimmunitymetabolites

Autor:innen und Institutionen

  • Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Robert J Vassar

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • Cure Alzheimer's Fund
  • National Institute on Aging

Zitieren

APA

Chandra, S., & Vassar, R. J. (2024). Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics. Immunological Reviews, 327(1), 33-42. https://doi.org/10.1111/imr.13412

Vancouver

Chandra S, Vassar RJ. Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics. Immunological Reviews. 2024;327(1):33-42. doi:10.1111/imr.13412

BibTeX
@article{Chandra2024,
  author = {Chandra, Sidhanth and Vassar, Robert J},
  title = {Gut microbiome‐derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics},
  journal = {Immunological Reviews},
  year = {2024},
  volume = {327},
  number = {1},
  pages = {33--42},
  doi = {10.1111/imr.13412}
}
Kostenlos starten →